@GlaikitInvestor I've actually been looking at it this week. Seems at a much more affordable level these days, although it's already had a decent run up.
Stop loss kicked in for my holding in #REL Relx
Held since early 2020 for a +94.8% return including divis
Sold at 3500p - seemed like a line of support, which if it fell could cost me a lot of my gains. TTM PE of 32 also tested my value / GARP preferences
I don't pay a lot of attention to charts, but I added to #PHP this week on the basis of it sitting just above support, a point it normally rebounds strongly from
8.18% forecast yield (historically growing 5% a year)
NAV 99p
Discount to NAV 9%
DYOR
@HTVIOLA Really sorry to hear this Henry, I've learnt a lot from your input on Twin Petes over the last few years.
Wishing you lots of luck with whatever ventures the future holds.
Smiths News (#SNWS) TU
📈 Full-year results expected ahead of market exp (£37.2m consensus)
⚽ Record £3m+ boost from the World Cup
🚚 Transformational work underway to expand national network ahead of 2027 contract rollout
📈 SP +4.44%
Full results 4/11 [I hold]
@thesamball Have you read this yet Sam? One of the best books I've read in years. True crime but plotted against a bit of an overview of London's financial history.
Bought a small starter position in #RMV Rightmove.
Op Margin 67.7%
PE(f) 13
Yield 2.81%
Revenue CAGR 15.6%
EPS CAGR 17.5%
Just popped above 50dma
Company doing all the right things yet share price cut in half due to the perceived threat of AI
#W7L back above the 200dma for the first time in a while. Once a share every PI seemed to own, now firmly out in the cold. Is it a buy at this point?
PE(f) 10.7, yield 6.2%, EPS growth 14%.
@conkers3@masterinvestor I've been tempted many times. This video is a good overview of their problems from a non-investing perspective.
https://t.co/UGIoFGHoHh
@1James1n1 Thoughts as a marathon runner myself: I'll definitely be picking up a pair of these. ASICS, Adidas, Puma all get great reviews, and a lot of hype around Li-Ning racing shoes (£80 or so on Shien / AE).
ZTF are hugely connected to Nike who have a lot more worthy competition now.
@micliffo Yeah, i suspect some sort of "microdose" regime once you've finished the actual course of weight loss.
Novo are such a strong company I'm quite sure they've been developing this for some time already.
Good to see $NVO creeping above the 200-day SMA.
Prices at 2022 levels, but revenue 86% higher and profits 107% higher.
Headwinds from the higher efficacy of $LLY Eli Lilly products exist, but they're also the first to gain US approval for tablet form GLP1 medication.
[I hold]
@s1m_j@investwithwes1 I have mates that work in big accounting firms - they're unable to invest in any company they work with (even though one mate is in HR with no access to the accounts).
Some are not even able to invest in companies their husband's / wive's company work with.